PRAXIS PRECISION MEDICINES, INC. Payments for Repurchase of Redeemable Convertible Preferred Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- PRAXIS PRECISION MEDICINES, INC. payments for repurchase of redeemable convertible preferred stock for the quarter ending 2021-12-31 was $0.00.
- PRAXIS PRECISION MEDICINES, INC. payments for repurchase of redeemable convertible preferred stock for the quarter ending 2021-09-30 was $0.00.
- PRAXIS PRECISION MEDICINES, INC. payments for repurchase of redeemable convertible preferred stock for the quarter ending 2021-06-30 was $0.00.
- PRAXIS PRECISION MEDICINES, INC. payments for repurchase of redeemable convertible preferred stock for the quarter ending 2021-03-31 was $0.00, a 100.00% decline year-over-year.
- PRAXIS PRECISION MEDICINES, INC. payments for repurchase of redeemable convertible preferred stock for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- PRAXIS PRECISION MEDICINES, INC. payments for repurchase of redeemable convertible preferred stock for fiscal 2020 was $30.00M.
- PRAXIS PRECISION MEDICINES, INC. payments for repurchase of redeemable convertible preferred stock for fiscal 2019 was $0.00.
| Period end | Payments for Repurchase of Redeemable Convertible Preferred Stock 3 month | Payments for Repurchase of Redeemable Convertible Preferred Stock 12 month |
|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $0.00 10-K · filed 2022-02-28 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $0.00 derived: sum of 4 quarters · filed 2022-02-28 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $0.00 derived: sum of 4 quarters · filed 2022-02-28 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-11 | $0.00 derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $30.00M 10-K · filed 2022-02-28 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | |
| 2020-03-31 | $30.00M 10-Q · filed 2021-05-11 | |
| 2019-12-31 | $0.00 10-K · filed 2021-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |